Novel naltrexone hydrochloride nanovaccine based on chitosan nanoparticles promotes induction of Th1 and Th17 immune responses resulting in protection against Toxoplasma gondii tachyzoites in a mouse model
Zohreh Khorshidvand, Afra Khosravi, Mohammad Mehdi Mahboobian, Amir Larki‐Harchegani, Mohammad Fallah, Amir Hossein Maghsood
Topics & Concepts
AdjuvantToxoplasma gondiiImmune systemChemistryToxoplasmosisRecombinant DNAChitosanIn vivoAntigenAntibodyBiologyImmunologyBiochemistryGeneBiotechnologyToxoplasma gondii Research StudiesAntimicrobial agents and applicationsImmune Response and Inflammation